AngioJet Reduces Complications, Coronary Events Compared To Urokinase
This article was originally published in The Gray Sheet
Executive Summary
Possis Medical's AngioJet LF140 rheolytic thrombectomy catheter can significantly reduce in-hospital major cardiac events, bleeding complications and vascular complications in patients with intracoronary thrombus as compared to intracoronary urokinase infusion, Stephen Ramee, MD, Ochsner Clinic, New Orleans, told attendees Nov. 9 at the American Heart Association's 71st annual Scientific Sessions in Dallas, Texas.